Sengwee Toh

52PUBLICATIONS
150CO-AUTHORS
PharmacogenomicsNutritional epidemiologyPredictive and prognostic markersInformation systems development methodologies and practiceMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (52)

|Jun 29, 2026
Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

|Jun 29, 2026
Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

|Feb 09, 2026
Post-authorization safety study to assess the risk of diabetic ketoacidosis among type 2 diabetes mellitus patients treated with ertugliflozin compared to patients treated with other antihyperglycaemic agents in a Medicare and Medicaid population.

Ashish Rai, James Marshall, Sampada Nandyala

|Jan 30, 2026
Discontinuation of Renin-Angiotensin System Inhibitors and Risk of End-Stage Renal Disease and Cardiovascular Outcomes Among Patients With Type 2 Diabetes and Chronic Kidney Disease: A Nationwide Taiwanese Cohort Study.

Yaa-Hui Dong, Chia-Hsuin Chang, Li-Chiu Wu

|Oct 09, 2025
Recommendations to Enable Broader Use of Real-World Evidence to Inform Decision-Making Throughout Pharmacovigilance Signal Management.

G Niklas Norén, Katherine Donegan, Monica A Muñoz

|Aug 12, 2025
Continuation Versus Discontinuation of Sodium-Glucose Cotransporter-2 Inhibitors and Cardiorenal Outcomes Among Patients With Type 2 Diabetes and Chronic Kidney Disease: A Nationwide Cohort Study With a Target Trial Emulation Framework.

Yaa-Hui Dong, Chia-Hsuin Chang, Li-Chiu Wu

Pageof 9

Frequent Collaborators

5 joint publications

Lockwood Taylor

5 joint publications

Judith C Maro

4 joint publications

Joshua J Gagne

4 joint publications

Catherine A Panozzo